Massive hydroxychloroquine overdoseYANTURALI, S; AKSAY, E; DEMIR, O. F et al.Acta anaesthesiologica scandinavica. 2004, Vol 48, Num 3, pp 379-381, issn 0001-5172, 3 p.Article

DRESS et hydroxychloroquine = Hydroxychloroquine and DRESSSCHMUTZ, J.-L; BARBAUD, A; TRECHOT, P et al.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 12, pp 903-903, issn 0151-9638, 1 p.Article

Possible Protective Effect of Hydroxychloroquine on Delaying the Occurrence of Integument Damage in Lupus: LXXI, Data From a Multiethnic CohortPONS-ESTEL, Guillermo J; ALARCON, Graciela S; GONZALEZ, Luis A et al.Arthritis care and research. 2010, Vol 62, Num 3, pp 393-400, issn 0893-7524, 8 p.Article

Successful Desensitization for Hydroxychloroquine AnaphylaxisDIAZ DONADO, Carmen; MAQUIERA DIEZ, Elena.Journal of rheumatology. 2010, Vol 37, Num 9, pp 1975-1977, issn 0315-162X, 3 p.Article

The use of antimalarials in dermatologyTREHAN, M.Journal of dermatological treatment. 2000, Vol 11, Num 3, pp 185-194, issn 0954-6634Article

Desensitization to hydroxychloroquine: Experience of 4 patientsMATES, Michal; ZEVIN, Shoshana; BREUER, Gabriel S et al.Journal of rheumatology. 2006, Vol 33, Num 4, pp 814-816, issn 0315-162X, 3 p.Article

Ophthalmological monitoring for hydroxychloroquine toxicity : A scientific review of available dataSILMAN, A; SHIPLEY, M.British journal of rheumatology. 1997, Vol 36, Num 5, pp 599-601, issn 0263-7103Article

Short Communication: Preferential Concentration of Hydroxychloroquine in Adenoid Tissue of HIV-Infected SubjectsAGUIRRE-CRUZ, Lucinda; TORRES, Klintsy J; JUNG-COOK, Helgi et al.AIDS research and human retroviruses. 2010, Vol 26, Num 3, pp 339-342, issn 0889-2229, 4 p.Article

Hydroxychloroquine in lupus pregnancyCLOWSE, Megan E. B; MAGDER, Laurence; WITTER, Frank et al.Arthritis and rheumatism. 2006, Vol 54, Num 11, pp 3640-3647, issn 0004-3591, 8 p.Article

ERG findings in patients using hydroxychloroquineTZEKOV, Radouil T; SERRATO, Alexandra; MARMOR, Michael F et al.Documenta ophthalmologica. 2004, Vol 108, Num 1, pp 87-97, issn 0012-4486, 11 p.Article

Ocular toxicity and hydroxychloroquine : guidelines for screeningJONES, S. K.British journal of dermatology (1951). 1999, Vol 140, Num 1, pp 3-7, issn 0007-0963Article

L'apport de l'électrorétinographie multifocale dans le suivi des patients traités par hydroxychloroquine = Multifocal electroretinography in follow-up of patients treated with hydroxychloroquineALIFERIS, K; MERMOUD, C; SAFRAN, A. B et al.Journal français d'ophtalmologie. 2011, Vol 34, Num 7, pp 468-475, issn 0181-5512, 8 p.Conference Paper

Multifocal electroretinographic evaluation of Long-term hydroxychloroquine usersMATURI, Raj K; MINZHONG YU; WELEBER, Richard G et al.Archives of ophthalmology (1960). 2004, Vol 122, Num 7, pp 973-981, issn 0003-9950, 9 p.Article

Clinical characteristics of hydroxychloroquine retinopathyPAYNE, John F; HUBBARD, G. Baker; AABERG, Thomas M et al.British journal of ophthalmology. 2011, Vol 95, Num 2, pp 245-250, issn 0007-1161, 6 p.Article

Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample studyCANKAYA, Hulya; ALPÖZ, Esin; KARABULUT, Gonca et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2010, Vol 110, Num 1, pp 62-67, issn 1079-2104, 6 p.Article

Micropapular Cutaneous Sarcoidosis : Case Series Successfully Managed With Hydroxychloroquine SulfateMODI, Sapna; ROSEN, Ted.Cutis (New York, NY). 2008, Vol 81, Num 4, pp 351-354, issn 0011-4162, 4 p.Article

Comment prévenir la toxicité oculaire de l'hydroxychloroquine? = Prevention of ocular toxicity induced by hydroxychloroquineSAMSOEN, M.Les Nouvelles dermatologiques. 1999, Vol 18, Num 6, issn 0752-5370, p. 410Conference Paper

Hydroxychloroquine: A Treatable Cause of CardiomyopathyABBASI, Siddique; TARTER, Laura; FARZANEH-FAR, Ramin et al.Journal of the American College of Cardiology. 2012, Vol 60, Num 8, issn 0735-1097, p. 786Article

Hydroxychloroquine Modulates Metabolic Activity and Proliferation and Induces Autophagic Cell Death of Human Dermal FibroblastsRAMSER, Bettina; KOKOT, Agatha; METZE, Dieter et al.Journal of investigative dermatology. 2009, Vol 129, Num 10, pp 2419-2426, issn 0022-202X, 8 p.Article

Hallucinations au cours d'un traitement par hydroxychloroquine = Hallucinations during treatment with hydrochloroquineFERRARO, V; MANTOUX, F; DENIS, K et al.Annales de dermatologie et de vénéréologie. 2004, Vol 131, Num 5, pp 471-473, issn 0151-9638, 3 p.Article

Hydroxychloroquine retinopathyMATURI, R. K; FOLK, J. C; NICHOLS, B et al.Archives of ophthalmology (1960). 1999, Vol 117, Num 9, pp 1262-1263, issn 0003-9950Article

Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practiceLEVY, G. D; MUNZ, S. J; PASCHAL, J et al.Arthritis and rheumatism. 1997, Vol 40, Num 8, pp 1482-1486, issn 0004-3591Article

Comparison of Screening Procedures in Hydroxychloroquine ToxicityMARMOR, Michael F.Archives of ophthalmology (1960). 2012, Vol 130, Num 4, pp 461-469, issn 0003-9950, 9 p.Article

Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicityPASADHIKA, S; FISHMAN, G. A; CHOI, D et al.Eye (London. 1987). 2010, Vol 24, Num 5, pp 757-762, issn 0950-222X, 6 p.Article

Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquineBERGHOLZ, R; SCHROETER, J; RUTHER, K et al.British journal of ophthalmology. 2010, Vol 94, Num 12, pp 1637-1642, issn 0007-1161, 6 p.Article